Health

Zentiva presents its Sustainability Report 2024
En croissance de 36 %, APRIL réaffirme son ambition de devenir le premier courtier d'assurance européen d'envergure mondiale dans le mass market
With 36% growth, APRIL reaffirms its ambition to become Europe's leading world-class insurance broker in the mass market
Infinitopes Granted Phase I/IIa Clinical Trial Application Approval to Evaluate Precision Vaccine Targeting Early-Stage Oesophageal Cancer
Precision for Medicine s'associe à SOPHiA GENETICS pour étendre ses services biopharmaceutiques avec la plateforme SOPHiA DDM™ et ses capacités de biopsie liquide
Pro-suicide forum subject of first Ofcom probe, BBC understands
Major Cost Savings on Top Cancer Drugs with India-Approved Alternatives
GC Biopharma Receives MFDS Approval for World's First Recombinant Anthrax Vaccine
Remegen Announces Exciting Results of Telitacicept Phase 3 Clinical Trial for Patients with Generalized Myasthenia Gravis
VARON Expands Access to Oxygen Therapy--Breathing Easier, Living Stronger
WELL Health to Report Fourth Quarter and Year End 2024 Financial Results on April 14, 2025
Bourhis Law Group: Judge Orders Insurance Company to Pay Celebrated Doctor $150,000
The Inner Circle acknowledges, Sabrina Rene, MD, FACE as a Pinnacle Professional Member
TIBSOVO's Continued Success Solidifies Its Position as a Leader in IDH1 Mutant Space | DelveInsight
Precision for Medicine geht mit SOPHiA GENETICS eine Partnerschaft ein, um seine Biopharma-Dienstleistungen mit der SOPHiA DDM™-Plattform und ihren Liquid-Biopsy-Funktionen zu erweitern
Activistas de California piden a los legisladores rechazar el proyecto de ley AB 342
Einstein Research Leads to Designation of New Type of Diabetes
Health In Tech to Announce First Quarter 2025 Financial Results on April 14, 2025
SPL Now Offers Dioxin Testing Services to Support Environmental and Public Health Initiatives
Select Medical Holdings Corporation to Announce First Quarter 2025 Results on Thursday, May 1, 2025